Pfizer Launches US Pilot Programme for Delivery and Distribution of COVID-19 Vaccine- BNT162b2
Shots:
- Pfizer launched a pilot program to support the state’s planning- deployment & administration of the COVID-19 vaccine candidate- to build on coordination with the relevant US agencies
- Pfizer has been working with US officials in OWS & the US CDC to help ensure that after potential authorization or approval- the Pfizer-bioNtech COVID-19 vaccine can reach those in most need as quickly and equitably as possible
- The BNT162b2 COVID-19 vaccine is not currently approved for distribution anywhere in the world- both collaborators are committed to developing these novel vaccines with preclinical & clinical data at the forefront of all their decision making
Ref: Pfizer | Image: Pfizer
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com